EP1789084
Minnkun á mögulegum læknisfræðilegum áhættuþáttum tengdum inflúensubóluefnum.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
9.9.2005EP published:
17.11.2010EP application number:
05795012.3
EP translation filed:
4.1.2011Grant published:
15.1.2011EPO information:
European Patent Register
Max expiry date:
8.9.2025Expiry date:
8.9.2014
Title:
DECREASING POTENTIAL IATROGENIC RISKS ASSOCIATED WITH INFLUENZA VACCINES
Timeline
Today
9.9.2005EP application
17.11.2010EP Publication
4.1.2011Translation submitted
15.1.2011Registration published
8.9.2014Expires
Owner
Name:
Novartis Vaccines and Diagnostics GmbHAddress:
Emil-von-Behring-Strasse 76, 35041, Marburg, DE
Inventor
Name:
GREGERSEN, Jens-Peter,Chiron Behring GmbH & Co.Address:
Marburg, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
04255471Date:
9.9.2004Country:
EP
Classification
Categories:
A61K 39/145, C12Q 1/70
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 11.8.2011
Expires: 8.9.2012
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 8.8.2012
Expires: 8.9.2013
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 8.8.2013
Expires: 8.9.2014
Payer: Árnason Faktor